SHEMESH SHAY (Chief Development Officer) received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/9/2026ACC: 0001104659-26-002501
Officer· Chief Development Officer
Since Feb 2022
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
9.1%
1/6/2026
1.64M→1.79M
Total
Net shares
+150K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | A · Award | +150K | — | — | 9.1% | 1.64M | 1.79M |
| Total | +150K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported